![86-9668-96 Mouse anti-Human IgG light chain(kappa chain)-HRP Conjugated Antibody 100ul C48076-AF488 【AXEL】 アズワン 86-9668-96 Mouse anti-Human IgG light chain(kappa chain)-HRP Conjugated Antibody 100ul C48076-AF488 【AXEL】 アズワン](https://aimg.as-1.co.jp/c/86/9668/94/86635011.jpg?v=0926545681e058f44554298ccedcbd58c6c2cef6)
86-9668-96 Mouse anti-Human IgG light chain(kappa chain)-HRP Conjugated Antibody 100ul C48076-AF488 【AXEL】 アズワン
![Invitrogen Goat anti-Human IgG (Kappa light chain) Recombinant Secondary Antibody, HRP, Invitrogen™ 250 μL; HRP Invitrogen Goat anti-Human IgG (Kappa light chain) Recombinant Secondary Antibody, HRP, Invitrogen™ | Fisher Scientific Invitrogen Goat anti-Human IgG (Kappa light chain) Recombinant Secondary Antibody, HRP, Invitrogen™ 250 μL; HRP Invitrogen Goat anti-Human IgG (Kappa light chain) Recombinant Secondary Antibody, HRP, Invitrogen™ | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/LSG/antibodies/A56864-GoatAntiHumanIgGKappaLightChainRecombinantSecondaryAntibodyHRP-ELISA1_20221205034358.jpg-650.jpg)
Invitrogen Goat anti-Human IgG (Kappa light chain) Recombinant Secondary Antibody, HRP, Invitrogen™ 250 μL; HRP Invitrogen Goat anti-Human IgG (Kappa light chain) Recombinant Secondary Antibody, HRP, Invitrogen™ | Fisher Scientific
![Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS](https://www.pnas.org/cms/10.1073/pnas.1901734117/asset/3df9a166-9499-4800-a9f7-49e5fac85081/assets/graphic/pnas.1901734117fig01.jpeg)
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
![Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721012250-fx1.jpg)